NIH’s NIAID Launches ClinRegs Website for Global Clinical Research Regulations
The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), has launched ClinRegs, a public website designed to help clinical researchers navigate country-specific regulatory information as they plan and implement clinical trials. Organized by country and topic area, the site also allows users to compare the requirements of two countries side-by-side.
Topic areas addressed on the website include clinical trial lifecycle, competent authority oversight, ethics committee oversight, informed consent, investigational products, specimens, and sponsorship.
ClinRegs currently includes clinical research regulatory information summarized in English for Brazil, China, India, Kenya, Liberia, Malawi, Peru, Sierra Leone, South Africa, Tanzania, Thailand, Uganda, United Kingdom and the United States. The ClinRegs team plans to further expand its country list in alignment with NIAID research priorities, including Guinea, Mali, Mexico, and Vietnam.
NIAID plans to review regulations for each country on a regular basis-approximately once per year-and more often if it learns of major regulatory changes. NIAID strives to make ClinRegs a useful resource for and the clinical research community and welcomes comments, insights, and suggestions via its feedback survey on the website. To access the ClinRegs site, go to clinregs.niaid.nih.gov.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
